These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2913481)

  • 1. Phase II trial of amsacrine in patients with multiple myeloma.
    Greipp PR; Coleman M; Anderson K; McIntyre OR
    Med Pediatr Oncol; 1989; 17(1):76-8. PubMed ID: 2913481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study.
    Ahmann FR; Meyskens FL; Jones SE; Bukowski RM; Saiers JH; Ryan DH; Costanzi J; Vaughn CB; Coltman CA
    Cancer Treat Rep; 1983; 67(7-8):697-700. PubMed ID: 6688199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of AMSA in head and neck cancer.
    Crivellari D; Tirelli U; Frustaci S; Veronesi A; Galligioni E; Tumolo S; Grigoletto E
    Am J Clin Oncol; 1987 Feb; 10(1):23-5. PubMed ID: 3825990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot study of adriamycin and amsacrine (m-AMSA) in patients with advanced breast cancer.
    Chang AY; Solan A; Kaplan BH; Vogl SE; Camacho FJ; Taylor SG
    Am J Clin Oncol; 1988 Oct; 11(5):535-7. PubMed ID: 3177254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of m-AMSA therapy in refractory Hodgkin's disease and non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 7972.
    Rybak ME; Anderson JR; Poulin RF; Amrein PC; Canellos GP; Gottlieb AJ
    Cancer Treat Rep; 1986 Oct; 70(10):1233-4. PubMed ID: 3530451
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
    Woodcock TM; Schneider RJ; Young CW
    Cancer Treat Rep; 1980 Jan; 64(1):53-5. PubMed ID: 6892893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II clinical trial of domestic amsacrine in patients with acute leukemias. Cooperative Group for Treating Acute Leukemias with Domestic m-AMSA].
    Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):80-4. PubMed ID: 8404329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment with m-AMSA in the blast crisis of chronic myeloid leukemia].
    Cervantes F; López Guillermo A; Rozman M; Rozman C
    Sangre (Barc); 1988 Dec; 33(6):471-3. PubMed ID: 3247620
    [No Abstract]   [Full Text] [Related]  

  • 9. Effective reinduction therapy for childhood acute nonlymphoid leukemia using simultaneous continuous infusions of teniposide and amsacrine.
    Mirro J; Kalwinsky DK; Grier HE; Santana VM; Mason C; Murphy SB; Dahl GV
    Cancer Chemother Pharmacol; 1989; 24(2):123-7. PubMed ID: 2731312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of amsacrine (m-AMSA) in advanced lymphomas: a Southwest Oncology Group study.
    Weick JK; Jones SE; Ryan DH
    Cancer Treat Rep; 1983 May; 67(5):489-92. PubMed ID: 6687839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of m-AMSA in patients with small-cell lung cancer.
    Natale RB; Gralla RJ; Wittes RE
    Cancer Clin Trials; 1981; 4(4):393-5. PubMed ID: 6274533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) versus amsacrine in patients with transitional cell carcinoma of the urinary bladder: a Southwest Oncology Group study.
    Al-Sarraf M; Frank J; Smith JA; O'Bryan RM; Costanzi JJ; Stephens RL; Caraveo J; Crawford ED
    Cancer Treat Rep; 1985 Feb; 69(2):189-94. PubMed ID: 2578880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study with amsacrines (m-AMSA and m-AMSA lactate) in refractory lymphomas.
    Bajetta E; Buzzoni R; Viviani S; Villani F; Piotti P; Gasparini G; Bonadonna G
    Cancer Treat Rep; 1985 Sep; 69(9):965-9. PubMed ID: 3839714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m-AMSA: phase II trial in advanced lymphoma and leukemia.
    Case DC
    Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I trial of the amsacrine analogue 9-[( 2-methoxy-4-[(methylsulfonyl)amino]-phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921).
    Hardy JR; Harvey VJ; Paxton JW; Evans P; Smith S; Grove W; Grillo-Lopez AJ; Baguley BC
    Cancer Res; 1988 Nov; 48(22):6593-6. PubMed ID: 3180070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia.
    Legha SS; Keating MJ; Zander AR; McCredie KB; Bodey GP; Freireich EJ
    Ann Intern Med; 1980 Jul; 93(1):17-21. PubMed ID: 6930826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day schedule.
    Fyfe D; Price C; Langley RE; Pagonis C; Houghton J; Osborne L; Woll PJ; Gardner C; Baguley BC; Carmichael J;
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):333-7. PubMed ID: 11345650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of m-AMSA in head and neck cancer.
    Forastiere AA; Young CW; Wittes RE
    Cancer Chemother Pharmacol; 1981; 6(2):145-6. PubMed ID: 6895486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of the amsacrine analogue CI-921 (NSC 343499) in non-small cell lung cancer.
    Harvey VJ; Hardy JR; Smith S; Grove W; Baguley BC
    Eur J Cancer; 1991; 27(12):1617-20. PubMed ID: 1664218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-step reevaluation of high-dose amsacrine for advanced carcinoma of the upper aerodigestive tract: a pilot phase II study.
    Jelic S; Nikolic-Tomasevic Z; Kovcin V; Milanovic N; Tomasevic Z; Jovanovic V; Vlajic M
    J Chemother; 1997 Oct; 9(5):364-70. PubMed ID: 9373792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.